Glucose lowering strategies with insulin
- 17 December 2019
- journal article
- research article
- Published by ABCD Diabetes Care, Ltd. in British Journal of Diabetes
- Vol. 19 (2), 124-130
- https://doi.org/10.15277/bjd.2019.228
Abstract
People with type 1 diabetes must use insulin and a large fraction of those with type 2 condition also do so. Many therefore struggle with the unpredictable balancing of insulin dose with calorie intake and utility. A healthy pancreas makes meticulous adjustment on a continuous basis that present therapeutic insulin administration cannot match. However, much progress has been made to make it simpler to inject both background and fast-acting boost insulins with a view to better mimicking normal pancreatic output. The present fast insulins are reviewed with accent on the primary amino acid structures of the biosynthetic types that diffuse more quickly than regular insulin that associates in hexamers. This makes boost doses kinetically and clinically more effective, allowing people to inject better estimated boost and corrective doses. Formulation advances are discussed for their present and potential contributions. The newer slow-acting insulins are also described and compared, their advantage also being kinetic with a lower likelihood of inducing overnight hypoglycaemia when used optimally. Finally, the appreciation of the advantages of alternative routes of administration such as oral and peritoneal are included in this review because of the possibility of altering the hepatic to peripheral ratio, the reasons for which are more effective but less obesogenic insulin activity. The logistics of oral insulin are summarised in terms of the risks to the insulin structure, the facilitation of paracellular uptake at the apical surface and the paradoxically advantageous hepatic first pass. Other non-invasive routes are also included in the review.Keywords
This publication has 49 references indexed in Scilit:
- LY2605541—A Preferential Hepato-Specific Insulin AnalogueDiabetes, 2014
- N-alkylation of highly quaternized chitosan derivatives affects the paracellular permeation enhancement in bronchial epithelia in vitroEuropean Journal of Pharmaceutics and Biopharmaceutics, 2014
- A contrast between children and adolescents with excellent and poor control: the T1D exchange clinic registry experiencePediatric Diabetes, 2013
- Trends in drug delivery through tissue barriers containing tight junctions.Tissue Barriers, 2013
- Defective Counterregulation and Hypoglycemia Unawareness in Diabetes: Mechanisms and Emerging TreatmentsEndocrinology and Metabolism Clinics of North America, 2013
- Polymeric hydrogels for oral insulin deliveryJournal of Controlled Release, 2013
- Strategies for effective oral insulin delivery with modified chitosan nanoparticles: A reviewProgress in Polymer Science, 2012
- Molecular origins of surfactant-mediated stabilization of protein drugsAdvanced Drug Delivery Reviews, 2011
- Mechanism and consequence of chitosan-mediated reversible epithelial tight junction openingBiomaterials, 2011
- Physiology and Function of the Tight JunctionCold Spring Harbor Perspectives in Biology, 2009